I think that would be a very real concern that will need to be evaluated post approval.

The approval was based on the device efficacy as a surgical tool for removing tumors, not as a treatment for cancer. Because of this, the trials did not look at long term outcomes like if the procedure leads to the cancer recurrence or spread.

In practice, The device will likely be used in conjunction with chemo, to try to hunt down metastatic cells.